Relationship of Nonstaging Pathological Risk Factors to Lymph Node Metastasis and Recurrence in Clinical Stage I Endometrial Carcinoma
- 30 September 1997
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 66 (3) , 388-392
- https://doi.org/10.1006/gyno.1997.4788
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cellsLeukemia & Lymphoma, 1996
- Steroid Hormone Receptor Content and Lymph Node Status in Endometrial CancerGynecologic Oncology, 1995
- Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survivalImmunology Today, 1994
- Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinomaCancer, 1994
- Insights from transgenic mice regarding the role ofbcl-2 in normal and neoplastic lymphoid cellsPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1994
- Traditional and Nontraditional Histopathologic Predictors of Recurrence in Uterine Endometrioid AdenocarcinomaGynecologic Oncology, 1994
- Prognostic value of steroid hormone receptors concentration in patients with endometrial CarcinomaActa Obstetricia et Gynecologica Scandinavica, 1994
- Flow cytometric studies of ploidy and proliferative indices in the Yorkshire trial of adjuvant progestogen treatment of endometrial cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Analysis of oncogene alterations in human endometrial carcinoma: Prevalence of ras mutationsMolecular Carcinogenesis, 1991
- DNA Ploidy in Endometrial Carcinoma: Major Objective Prognostic FactorMayo Clinic Proceedings, 1990